2009 · LIVER TRANSPLANTATION

Infliximab Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: A Case Report

Piton, Gael, Larosa, Fabrice, Minello, Anne, Becker, Marie-Claude, Mantion, Georges, Aubin, Francois, Deconinck, Eric, Hillon, Patrick, Di Martino, Vincent

Journal
LIVER TRANSPLANTATION
Année
2009
Volume
15
Numéro
7
Pages
682-685
Mois
JUL
DOI
10.1002/lt.21793

Abstract

Acute graft-versus-host disease (GVHD) following orthotopic liver transplantation is a rare but severe disease with a 75% death rate in adults. Various therapeutic strategies have been proposed for steroid-refractory GVHD, but there is still no consensus. Tumor necrosis factor-alpha is a key inflammatory cytokine involved in acute GVHD physiopathology, and infliximab has shown encouraging results for the treatment of acute GVHD following hematopoietic stem cell transplantation. We report the first case of acute GVHD following liver transplantation that was refractory to steroids and anti-lymphocyte globulin but was successfully ;treated with infliximab. Liver Transpl 15:682-685, 2009. (C) 2009 AASLD.

Lire l'article complet